Drug Shortage Report for TAZORAC

Last updated on 2020-03-10 History
Report ID 93947
Drug Identification Number 02243895
Brand name TAZORAC
Common or Proper name TAZORAC CREAM 0.1% 30 G
Company Name ALLERGAN INC
Market Status MARKETED
Active Ingredient(s) TAZAROTENE
Strength(s) 0.1%
Dosage form(s) CREAM
Route of administration TOPICAL
Packaging size 30 gram
ATC code D05AX
ATC description ANTIPSORIATICS FOR TOPICAL USE
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2019-09-16
Actual start date 2019-09-16
Estimated end date 2020-02-20
Actual end date 2020-03-09
Shortage status Resolved
Updated date 2020-03-10
Company comments
Health Canada comments
Company contact information Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2020-03-10 English Compare
v9 2020-03-09 French Compare
v8 2020-03-09 English Compare
v7 2019-12-05 French Compare
v6 2019-12-05 English Compare
v5 2019-11-08 French Compare
v4 2019-11-08 English Compare
v3 2019-09-17 English Compare
v2 2019-09-16 French Compare
v1 2019-09-16 English Compare